EVALUATION OF THE EFFECT OF THE PERFECTA V-BEAM LASER ON ROSACEA

Not Applicable

• Conditions: Rosacea

• Registration Number: NCT03211585
• Lead Sponsor: Syneron Medical

Brief Summary

The purpose of this study is to further quantify the safety and effectiveness of the Syneron-Candela long pulse-duration, extended sub-pulse, larger spot-size prototype Perfecta V-Beam, 595nm laser system for the treatment of facial redness associated with flushing and blushing, or rosacea. The Perfecta laser system is expected to provide effective treatment of rosacea with less bruising or purpura and greater effectiveness than previous generation systems. This study should enable optimization of treatment parameters for using the Perfecta 595nm laser for treating rosacea.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-10
• Status Verified: 2017-07
• Study First Submitted: 2017-07-05
• Study First Submitted QC: 2017-07-05
• Study First Posted: 2017-07-07
• Last Update Submitted: 2017-07-09
• Last Update Posted: 2017-07-12
• Primary Completion: 2018-04
• Study Completion: 2018-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• Subjects must have a Fitzpatrick skin type of I-IV and have Rosacea as evaluated by the treating physician.
• Subjects must have visible telangiectasia on the side of the face.
• Subjects must be willing and able to comply with all follow-up requirements.
• Subjects must be willing and able to apply sunblock SPF of 30 while exposed to the sun.
• Subject willing to have photographs taken and used in presentations or publications.

Exclusion Criteria

• Subjects must not have had a previous laser treatment, deep chemical peel in the intended treatment site(s) within 6 months prior to treatment, oral retinoids within 6 months of their inclusion into this study or have ever taken gold therapy.
• Subjects must not have a history of keloid formation.
• Subjects with Fitzpatrick Classification of V or VI (to reduce the risk of hyper-pigmentation).
• Subjects must be willing and able to comply with all follow-up requirements.
• Subjects cannot have vitiligo, a condition where pigment is lost in the skin and white patches appear).
• Subjects not willing to avoid sun exposure or not will to apply sunblock SPF of 30 while exposed to the sun.
• Subject not willing to have photographs taken and used in presentations, publications and marketing material

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
The percentage reduction in the facial redness and telangiectasias of rosacea	two months following the final treatment	The percentage reduction in the facial redness and telangiectasias of rosacea will be determined by the investigators using polarized photography for each subject